ArticleJournal of palliative medicine2020
Acute Care Utilization at End of Life in Sickle Cell Disease: Highlighting the Need for a Palliative Approach.
Article in Journal of palliative medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Clinician attitudes toward palliative care to enhance the quality of life for patients with sickle cell disease.Journal of sickle cell disease · 2025Article
- End-of-life care for people with sickle cell disease: barriers to and facilitators of high-quality care.Hematology. American Society of Hematology. Education Program · 2024Review
- Pregnancy outcomes in women with sickle cell disease in California.American journal of hematology · 2023Article
- Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study.BMJ open · 2022Article
- Sickle cell disease and COVID-19 in pregnant women.Journal of gynecology obstetrics and human reproduction · 2022Article
- Article
- Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease.Health science reports · 2021Article
- Understanding sickle cell disease: impact of surveillance and gaps in knowledge.Blood advances · 2020Article
- End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.Blood advances · 2019Article
- Case Ascertainment of Sickle Cell Disease Using Surveillance or Single Administrative Database Case Definitions.Public health reports (Washington, D.C. : 1974)Article
- Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025).Hematology, transfusion and cell therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.